Walleye Trading
ABVX icon

Walleye Trading’s Abivax ABVX Stock Holding History

Walleye Trading’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$706K Sell
5,300
-11,500
-68% -$1.3M ﹤0.01% 2492
2026
Q1 		$1.87M Buy
16,800
+1,700
+11% +$201K ﹤0.01% 1752
2025
Q4 		$2.04M Buy
+15,100
New +$1.65M ﹤0.01% 1894

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Walleye Trading's ABVX Position: Q2 2026 in Review

Walleye Trading reduced its Abivax (ABVX) stake by 30% in Q2 2026, selling an estimated $337K and leaving 6,790 shares worth $905K. The position accounts for ﹤0.01% of the portfolio, ranked #2354.

Walleye Trading first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.41M in Q4 2025. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Walleye Trading held 6,790 shares of Abivax worth $905K as of Q2 2026.
  • Walleye Trading sold 2,979 Abivax shares in Q2 2026, an estimated $337K.
  • Abivax made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2354 holding.
  • Walleye Trading first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • Walleye Trading's Abivax position peaked at $2.41M in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.